Yu Wu

1.2k citations
51 papers · 760 indexed · 1 hit paper · h-index 14
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (4 papers)RNA modifications and cancer (4 papers)
Partner nations
ChinaSwedenIndia

In The Last Decade

Yu Wu

49 papers receiving 745 citations

Hit Papers

Synergistic efficacy unleashed: Co/Ni-based catalysts as ...2024202620252024255075

Peers

Yu Wu
Comparison fields: 5 of 115
  • Molecular Biology 396
  • Cancer Research 148
  • Materials Chemistry 78
  • Inorganic Chemistry 71
  • Oncology 67
Replace Guodong Cao with:
Guodong Cao China
Chun Yin China
Kathryn White United States
Hui Ming China
Haiyu Wang China
Shuping Zhou China
Naoko Okamoto Japan
Guoyu Zhang China
Yuichiro Hagiya Japan
Yongxiang Wang China
Yu Wu relative to Guodong Cao China Guodong Cao's profile →
Citations per field
00.5×1.5×
Guodong Cao · 1×
Citations per year

Countries citing papers authored by Yu Wu

Since Specialization
Citations

This map shows the geographic impact of Yu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wu more than expected).

Fields of papers citing papers by Yu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wu. The network helps show where Yu Wu may publish in the future.

Co-authorship network of co-authors of Yu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Wu. A scholar is included among the top collaborators of Yu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Wu. Yu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 8
5
Synergistic efficacy unleashed: Co/Ni-based catalysts as a versatile powerhouse for photocatalytic degradation of ornidazolebreakdown →
96
6 3
7 1
8 2
9 35
10 3
11 4
12 1
13 4
14 15
15 8
16 7
17 9
18 3
19 19
20 63

About Yu Wu

Yu Wu is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 51 papers that have together received 760 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (148 citations), Molecular Biology (396 citations) and Inorganic Chemistry (71 citations). Yu Wu has collaborated with scholars based in China, Sweden and India. Frequent co-authors include Liang Chu, Shizhong Bu, Xin Wang, Mohd. Muddassir, Aiguo Zhong, Istikhar A. Ansari, Weizhi Zhang, Wanshan Ning, Shaofeng Lin and Peiran Jiang. Their work appears in journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026